MedPath

Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer

Completed
Conditions
Breast Cancer
Registration Number
NCT00897416
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

RATIONALE: Collecting and storing samples of blood and studying them in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is examining biomarkers in women with a high risk or average risk of breast cancer.

Detailed Description

OBJECTIVES:

Primary

* Identify and validate serum biomarkers that can distinguish malignant from benign and normal breast conditions in women at high risk or average risk for breast cancer.

Secondary

* Standardize procedures for recruitment, characterization, and follow-up of participants and collection, processing, storage, and analysis of specimens.

* Assess marker variability over time in healthy controls.

* Develop a shared specimen resource to support ongoing early detection research.

OUTLINE: Blood samples are collected every 6 months and assayed for the presence of biomarkers.

PROJECTED ACCRUAL: A total of 625 participants will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1452
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biomarker evaluation for the early detection of breast cancer to improve outcomes for women at risk for breast cancer
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath